In a study, metastasectomy was associated with significantly longer median progression-free and overall survival in some mRCC patients. The following article features coverage from the 2020 ...

A study showed that mortality risk was reduced by 59% for patients who underwent complete metastasectomy compared with those who did not. Patients with metastatic renal cell carcinoma (mRCC) who ...

In an attempt to search for the evidence available in the literature to support an aggressive locoregional treatment for patients with pulmonary metastases, in 2005 the council of ESTS approved the ...

Please provide your email address to receive an email when new articles are posted on . “The research found patients who had surgery to remove metastases were about half as likely to have died of ...

Although new treatments can prolong progression-free and overall survival in patients with renal cell carcinoma (RCC), the cure rate remains low and surgical resection of the primary tumor and ...

An open-label, multicenter, randomized controlled study of mXELIRI versus FOLFIRI in combination with bevacizumab as the first-line treatment in metastatic colorectal cancer: A single-center report.

Up to 50% of patients with soft tissue sarcoma (STS) develop lung metastases. Effective systemic therapies for metastatic STS are currently limited; when possible, surgical removal of the lung ...

The cancer vaccine therapy using DCs derived from iPS cells (iPSDCs) expressing TAA gene. A single institute retrospective trial of concurrent chemotherapy with SIR-Sphere versus SIR-Sphere alone in ...

In metastatic renal cell carcinoma (RCC), surgical resection of both the primary tumor within the kidney and distant metastases can result in durable disease-free intervals in well-selected patients.

Since the use of vascular endothelial growth factor (VEGF)-targeted therapy became an option for frontline treatment of metastatic renal cell carcinoma (RCC) in the early 2000s, the role of ...

Pulmonary metastasectomy is common practice among surgeons, comprising nearly 15% of all lung resections. Pulmonary metastasectomy from a primary tumor elsewhere is widely believed to improve survival ...